Centivax

South San Francisco, United States

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

$37.0M raised

Mar 2026

Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Centivax raised?

Centivax has raised $37.0M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.

Who are Centivax's investors?

Centivax's investors include Structure Fund, Bill & Melinda Gates Foundation, NFX, Future Ventures, Amplify Partners.

Where is Centivax headquartered?

Centivax is headquartered in South San Francisco, United States.

What does Centivax do?

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

What stage is Centivax at?

Centivax is at the Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 30, 2026.

MLA

"Centivax — Funding & Investors." VCBacked, March 30, 2026, https://www.vcbacked.co/company/centivax. Accessed July 2, 2026.

APA

VCBacked. (2026). Centivax — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/centivax

Wikipedia (cite web)

{{cite web |title=Centivax — Funding & Investors |url=https://www.vcbacked.co/company/centivax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 30, 2026.